UTI vs MH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 03, 2026

UTI

29.5
AI Score
VS
MH Wins

MH

32.3
AI Score

Investment Advisor Scores

UTI

30score
Recommendation
AVOID NEW MONEY

MH

32score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric UTI MH Winner
Forward P/E 30.2115 17.452 MH
PEG Ratio 2.0124 0 Tie
Revenue Growth 7.2% 2.6% UTI
Earnings Growth -78.9% 9860.2% MH
Tradestie Score 29.5/100 32.3/100 MH
Profit Margin 3.9% 4.4% MH
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

UTI 1M: +11.3% · 3M: -11.0% MH 1M: -18.4% · 3M: -19.3%

Current Technical Phase

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 56.8 · Price: $23.00

MH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 32

RSI (14): 32.5 · Price: $10.95

Fundamentals Snapshot

Metric UTI MH
Market Cap — —
Forward P/E 31.3 6.2
Trailing P/E 38.0 29.9
Revenue (TTM) — —
Revenue Growth 0.1% -0.1%
Gross Margin 0.6% 0.8%
Operating Margin 0.0% 0.2%
EPS 0.61 0.36
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.